Log In

    Lineage Cell Therapeutics, Inc. (LCTX)

    Treating Diseases By Transplanting New Cells

    ā€Œ
    Robert LeBoyerMedia Inquiries
    Senior Life Sciences Analyst
    August 19, 2021
    Report ID: 23962
    Already Registered?
    Click the Get Report button to login and view the full report, with price target, fundamental analysis, and rating.
    Get Report

    Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

    Already Registered? Click the ā€˜Get Reportā€™ button to login and view the research report.

    Not a Member? Register Now to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    ā€Œ
    Lineage Cell Therapeutics, Inc.
    Lineage Cell Therapeutics, Inc.
    Healthcare
    Biotechnology
    Ticker
    LCTX
    Current Price
    $0.676 -2.52%
    Market Cap
    $127.7M
    Price Target
    Refer to Report
    Volume
    755.8K
    52wk Range
    $0.481 - $1.61
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Log In
    Ā© 2018-2025 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
    Log In